Literature DB >> 27102704

Molecular Targets of Honokiol: A Promising Phytochemical for Effective Cancer Management.

Courey Averett1, Sumit Arora1, Haseeb Zubair1, Seema Singh1, Arun Bhardwaj1, Ajay P Singh2.   

Abstract

Honokiol is a bioactive, biphenolic phytochemical, present in the aerial parts of plants classified under the genus Magnolia. It has been an important constituent of Asian traditional medicine and is used against many ailments. Honokiol possesses potent antioxidative, anti-inflammatory, antiangiogenic, and anticancer activities by targeting a variety of signaling molecules. Consequently, there has been immense interest in exploring its utility as a novel chemopreventive and therapeutic agent against several malignancies. In this chapter, we review the structure-function relationship of honokiol and its derivative compounds, the impact of honokiol on various phenotypes associated with cancer progression and metastasis, and its prominent molecular targets and pharmacokinetics. Clearly, the available data generate significant interest in this novel phytochemical and emerging information continues to provide strong support for its potential applicability in cancer management.
© 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anticancer effects; Honokiol; Molecular targets; Natural products

Year:  2014        PMID: 27102704     DOI: 10.1016/B978-0-12-802215-3.00009-4

Source DB:  PubMed          Journal:  Enzymes        ISSN: 1874-6047


  8 in total

1.  Activation of tumor suppressor LKB1 by honokiol abrogates cancer stem-like phenotype in breast cancer via inhibition of oncogenic Stat3.

Authors:  S Sengupta; A Nagalingam; N Muniraj; M Y Bonner; P Mistriotis; A Afthinos; P Kuppusamy; D Lanoue; S Cho; P Korangath; M Shriver; A Begum; V F Merino; C-Y Huang; J L Arbiser; W Matsui; B Győrffy; K Konstantopoulos; S Sukumar; P A Marignani; N K Saxena; D Sharma
Journal:  Oncogene       Date:  2017-06-05       Impact factor: 9.867

2.  Honokiol Induces Apoptosis, G1 Arrest, and Autophagy in KRAS Mutant Lung Cancer Cells.

Authors:  Lian-Xiang Luo; Ying Li; Zhong-Qiu Liu; Xing-Xing Fan; Fu-Gang Duan; Run-Ze Li; Xiao-Jun Yao; Elaine Lai-Han Leung; Liang Liu
Journal:  Front Pharmacol       Date:  2017-04-11       Impact factor: 5.810

Review 3.  SIRT3 in Cardiac Physiology and Disease.

Authors:  Christoph Koentges; Christoph Bode; Heiko Bugger
Journal:  Front Cardiovasc Med       Date:  2016-10-13

4.  Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.

Authors:  Kao-Jean Huang; Chin-Ho Kuo; Shu-Hsin Chen; Ching-Yen Lin; Ying-Ray Lee
Journal:  J Cell Mol Med       Date:  2018-01-24       Impact factor: 5.310

Review 5.  Targeting the JAK/STAT Signaling Pathway Using Phytocompounds for Cancer Prevention and Therapy.

Authors:  Sankhadip Bose; Sabyasachi Banerjee; Arijit Mondal; Utsab Chakraborty; Joshua Pumarol; Courtney R Croley; Anupam Bishayee
Journal:  Cells       Date:  2020-06-11       Impact factor: 6.600

6.  Absence of Sirt3 aggravates cisplatin nephrotoxicity via enhanced renal tubular apoptosis and inflammation.

Authors:  Dal Kim; Woong Park; Sik Lee; Won Kim; Sung Kwang Park; Kyung Pyo Kang
Journal:  Mol Med Rep       Date:  2018-08-03       Impact factor: 2.952

7.  Magnolia extract is effective for the chemoprevention of oral cancer through its ability to inhibit mitochondrial respiration at complex I.

Authors:  Qi Zhang; Gang Cheng; Jing Pan; Jacek Zielonka; Donghai Xiong; Charles R Myers; Liang Feng; Song Seok Shin; Young Heui Kim; Dinh Bui; Ming Hu; Brian Bennett; Kathleen Schmainda; Yian Wang; Balaraman Kalyanaraman; Ming You
Journal:  Cell Commun Signal       Date:  2020-04-07       Impact factor: 5.712

8.  Trichodermin Induces G0/G1 Cell Cycle Arrest by Inhibiting c-Myc in Ovarian Cancer Cells and Tumor Xenograft-Bearing Mice.

Authors:  Ying Gao; Sarah L Miles; Piyali Dasgupta; Gary O Rankin; Stephen Cutler; Yi Charlie Chen
Journal:  Int J Mol Sci       Date:  2021-05-09       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.